Gold Stocks: Only The Most Efficient Will Shine True
It is earnings season. For the world’s largest gold producers, profits continue to flow due to the sustained and historically high price for gold. A primary risk for all of these firms is a downturn...
View ArticleADP: An Excellent Pick in 2012
Automatic Data Processing (NASDAQ: ADP), with a market capitalization of about $26.6 billion, is the largest global provider of payroll, human resources, tax filing, data processing, and benefits...
View ArticlePepsi’s New Direction: Great For Shareholders
PepsiCo (NYSE: PEP) has a strong presence in the world beverage market, but unbeknownst to many is the fact that PepsiCo produces roughly half of its revenue each year through its foods division that...
View ArticleGoogle Will Sink On New Stock Split Plan
Google (GOOG) introduced plans for a stock split in its latest earnings report. Ordinarily good news, this split has investors concerned and confused as it would create a new class of non-voting shares...
View ArticleWhy Netflix Stinks
Netflix (NFLX) provides and sells subscription services for TV shows and movies, offering customers the choice of receiving DVDs by mail, or streaming its available content through various smart...
View ArticleHewlett-Packard: Ready For A Bullish Run Now
Hewlett-Packard (HPQ) is a well-known brand in the technology industry. Over the years, the company has managed to build a strong reputation in the global market with a diverse portfolio of products...
View ArticleAbbott: Don’t Sell This Stock
People are increasingly putting their money into health and well being, with the focus on living longer through the use of medicines and other artificial means. That means companies like Abbott (ABT)...
View Article6 Stocks That Could Rise On A Jobs Recovery
Trends of higher unemployment and lower workforce participation have started to reverse. More hiring benefits companies that engage in staffing and payroll support. In this article, I will discuss six...
View ArticleThe Pipeline Powerhouse You Can’t Afford To Miss
Pfizer's (PFE) current pipeline makes it a more attractive investment option than its peers and rivals. The company has 78 drugs in its pipeline currently. 53 of these drugs are in Phase 1 or Phase 2...
View ArticleNew Reasons To Go Long On Chevron Now
In the first week of December, Chevron (CVX) announced that it will spend almost $37 billion in 2013 across the world. The increased capital budget spending will be used for oil exploration and...
View Article
